{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:26:47Z","timestamp":1780720007901,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research: Neuroimaging"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.pscychresns.2006.02.001","type":"journal-article","created":{"date-parts":[[2006,10,24]],"date-time":"2006-10-24T17:57:34Z","timestamp":1161712654000},"page":"175-183","source":"Crossref","is-referenced-by-count":17,"title":["Dopamine D2 receptor occupancy by risperidone: Implications for the timing and magnitude of clinical response"],"prefix":"10.1016","volume":"148","author":[{"given":"Ana M.","family":"Catafau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iluminada","family":"Corripio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Schotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Carri\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pscychresns.2006.02.001_bib1","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0925-4927(01)00085-3","article-title":"Double-blind olanzapine versus haloperidol D2 receptor blockade in schizophrenic patients: a baseline\u2013endpoint 123I-IBZM SPECT study","volume":"107","author":"Bernardo","year":"2001","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0140-6736(92)91108-K","article-title":"Striatal dopamine D2-receptor blockade by typical and atypical neuroleptics","volume":"339","author":"Br\u00fccke","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/CLT-100102873","article-title":"The pharmacology and toxicology of atypical antipsychotic agents","volume":"39","author":"Burns","year":"2001","journal-title":"Journal of Toxicology. Clinical Toxicology"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib5","first-page":"259","article-title":"Brain SPECT in clinical practice. Part I: perfusion","volume":"42","author":"Catafau","year":"2001","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1176\/appi.ajp.157.6.1019","article-title":"Subjective experience and striatal dopamine D2 receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone","volume":"157","author":"De Haan","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib8","first-page":"1138","article-title":"Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in risperidone-treated schizophrenic patients","volume":"39","author":"Dresel","year":"1998","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF00442555","article-title":"D1- and D2-dopamine receptor occupancy during treatment during conventional and atypical neuroleptics","volume":"99","author":"Farde","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine","volume":"49","author":"Farde","year":"1992","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004850-199702001-00002","article-title":"D2 occupancy, extrapyramidal side effects and antipsychotic drug treatment: a pilot study with sertindole in healthy subjects","volume":"12","author":"Farde","year":"1997","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002139900333","article-title":"Predicting haloperidol occupancy of central dopamine D2 receptors from plasma levels","volume":"149","author":"Fitzgerald","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002130050492","article-title":"Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia","volume":"135","author":"Gefvert","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-2236(96)10064-3","article-title":"Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs","volume":"20","author":"Grace","year":"1997","journal-title":"Trends in Neuroscience"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1176\/ajp.157.1.127","article-title":"Striatal dopaminergic D2 receptor density measured by [123I] iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients","volume":"157","author":"Guardia","year":"2000","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib17","series-title":"Principles of Nuclear Medicine","first-page":"497","article-title":"Neuronal transmission","author":"Innis","year":"1995"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/syn.1035","article-title":"D2 but not D3 receptors are elevated after 9 or 11 months of chronic haloperidol treatment: influence of withdrawal period","volume":"40","author":"Joyce","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1176\/appi.ajp.158.3.360","article-title":"Does fast disassociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis","volume":"158","author":"Kapur","year":"2001","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib20","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","article-title":"A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transient high dopamine D2 receptor occupancy","volume":"57","author":"Kapur","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/ajp.153.2.183","article-title":"123I IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics","volume":"153","author":"Klemm","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0925-4927(97)00023-1","article-title":"Extrapyramidal side effects with risperidone and haloperidol at comparable D2 receptor occupancy levels","volume":"75","author":"Knable","year":"1997","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0925-4927(96)02839-9","article-title":"Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone","volume":"68","author":"K\u00fcfferle","year":"1996","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib25","first-page":"211","article-title":"Imaging dopamine transmission in schizophrenia. A review and meta-analysis","volume":"42","author":"Laruelle","year":"1998","journal-title":"Quarterly Journal of Nuclear Medicine"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/schbul\/17.2.263","article-title":"The mechanism of action of novel antipsychotic drugs","volume":"17","author":"Meltzer","year":"1991","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00004850-199511000-00003","article-title":"Central D2 receptor occupancy and effects of zuclopenthixol in humans","volume":"10","author":"Nyberg","year":"1995","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(96)00218-7","article-title":"A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects","volume":"16","author":"Nyberg","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-4347(97)00302-2","article-title":"Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in serum from patients co-medicated with other psychotropic drugs","volume":"698","author":"Olesen","year":"1997","journal-title":"Journal of Chromatography B. Biomedical Sciences and Applications"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib30","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/PR0.10.3.799-812","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib31","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0006-3223(98)00057-2","article-title":"The resting and activation issue of hypofrontality: a single photon emission computed tomography study in neuroleptic-na\u00efve and neuroleptic-free schizophrenic female patients","volume":"44","author":"Parellada","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0140-6736(92)90467-H","article-title":"Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia","volume":"340","author":"Pilowsky","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1017\/S0033291700025575","article-title":"Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I-IBZM SPECT","volume":"23","author":"Pilowsky","year":"1993","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s002130050017","article-title":"Atypical antipsychotics: are some more atypical than others?","volume":"148","author":"Remington","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib36","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0006-3223(97)00442-3","article-title":"D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-na\u00efve state and after neuroleptic treatment","volume":"43","author":"Schr\u00f6der","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.pscychresns.2006.02.001_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s002130050822","article-title":"In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol","volume":"141","author":"Tauscher","year":"1999","journal-title":"Psychopharmacology"}],"container-title":["Psychiatry Research: Neuroimaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492706000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925492706000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T23:58:15Z","timestamp":1547251095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925492706000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":36,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0925492706000242"],"URL":"https:\/\/doi.org\/10.1016\/j.pscychresns.2006.02.001","relation":{},"ISSN":["0925-4927"],"issn-type":[{"value":"0925-4927","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}